Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pierce Biotechnology is a premier developer and manufacturer of reagents, kits, and tools for protein biology research and analysis. Founded in 1950 as the Pierce Chemical Company, it established a global reputation for innovation in protein detection, purification, and modification. The company's portfolio includes industry-standard products such as the BCA Protein Assay and SuperSignal chemiluminescent substrates for Western blotting. In 1999, Pierce was acquired by Fisher Scientific, which later merged with Thermo Electron to form Thermo Fisher Scientific. Today, Pierce operates as a key brand within Thermo Fisher's Life Sciences Solutions group, continuing to support proteomics and drug discovery workflows. Its products are essential tools for researchers in academic, clinical, and pharmaceutical laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pierce.